Уноси

Clinical characteristics of patients with COVID-19 (2022-09)

K. Stanetić, M. Grujić, A. Grujić, Б. Станетић, С. Савић, М. Станетић, T. Resanović, Clinical characteristics of patients with COVID-19, pp. 86 - 93, Sep, 2022
Why patients with COPD visit their doctor so late? (2017-05)

К. Станетић, С. Савић, B. Stanetić, М. Станетић, Why patients with COPD visit their doctor so late?, Časopis udruženja pulmologa Republike Srpske, Vol. 7, No. 1-2, pp. 231 - 234, May, 2017
Analysis of stress level and burnout syndrome among physicians of different medical specialties in primary health care. (2019-06)

K. Stanetić, B. Marković, V. Petrović, B. Stanetić, Analysis of stress level and burnout syndrome among physicians of different medical specialties in primary health care., БИОМЕДИЦИНСКА ИСТРАЖИВАЊА, Vol. 10, No. 1, pp. 38 - 46, Jun, 2019
The Presence of Stress, Burnout Syndrome and the Most Important Causes of Working Stress Among Physicians in Primary Health Care – an Observational Study from Banja Luka, Bosnia and Herzegovina (2019-10)

K. Stanetić, V. Petrović, B. Marković, B. Stanetić, The Presence of Stress, Burnout Syndrome and the Most Important Causes of Working Stress Among Physicians in Primary Health Care – an Observational Study from Banja Luka, Bosnia and Herzegovina, Acta Medica Academica, Vol. 148, No. 2, pp. 159 - 166, Oct, 2019
ApPropRiateness of myOcardial revascUlarization assessed by SYNTAX Scores in patients with type 2 diabetes melliTus: the PROUST study* (2020-06)

B. Stanetić, M. Ostojic, Т. Ковачевић-Прерадовић, L. Kos, К. Станетић, A. Nikolić, M. Bojić, K. Huber, ApPropRiateness of myOcardial revascUlarization assessed by SYNTAX Scores in patients with type 2 diabetes melliTus: the PROUST study*, POSTEPY W KARDIOLOGII INTERWENCYJNEJ, Vol. 16, No. 2, pp. 153 - 161, Jun, 2020
Grown-up Congenital Heart Diseases. (2016)

Т. Ковачевић-Прерадовић, М. Станетић, П. Ковачевић, B. Stanetić, Grown-up Congenital Heart Diseases., Medical Faculty, University of Banja Luka, 2016
Role of COPD in Decision-Making Process of Myocardial Revascularisation: A Retrospective Analysis from a Single PCI-centre Without On-site Cardiac Surgery. (2015-05)

B. Stanetić, Т. Ковачевић-Прерадовић, М. Станетић, S. Lončar, Ž. Živanović, S. Srdić, K. Huber, P. Serruys, Role of COPD in Decision-Making Process of Myocardial Revascularisation: A Retrospective Analysis from a Single PCI-centre Without On-site Cardiac Surgery., Časopis udruženja pulmologa Republike Srpske, Vol. 5, No. 1-2, pp. 9 - 16, May, 2015
Chronic Obstructive Lung Disease In Non- Smockers. (2015-05)

К. Станетић, С. Савић, B. Stanetić, Chronic Obstructive Lung Disease In Non- Smockers., Časopis udruženja pulmologa Republike Srpske, Vol. 5, No. 1-2, pp. 181 - 185, May, 2015
High-Sensitive Troponin-T as a Predictive Outcome Factor in COVID-19 Hospitalised Patients: Analysis After One-Year Follow-Up (2021-06)

D. Stojanovic, Z. Cetojevic, B. Dujakovic, М. Станетић, Т. Ковачевић-Прерадовић, B. Stanetić, High-Sensitive Troponin-T as a Predictive Outcome Factor in COVID-19 Hospitalised Patients: Analysis After One-Year Follow-Up, SCRIPTA MEDICA, Vol. 52, No. 2, pp. 96 - 103, Jun, 2021
SYNTAX SCORE II VERSION 2020: EXTERNAL VALIDATION OF PATIENTS TREATED BY CORONARY ARTERY BYPASS GRAFTING IN A SINGLE LARGE VOLUME CARDIO-SURGICAL CENTER (2023-03)

B. Stanetić, SYNTAX SCORE II VERSION 2020: EXTERNAL VALIDATION OF PATIENTS TREATED BY CORONARY ARTERY BYPASS GRAFTING IN A SINGLE LARGE VOLUME CARDIO-SURGICAL CENTER, JACC, Mar, 2023
Integrating Machine Learning in Clinical Decision Support for Heart Failure Diagnosis: Case Study (2024-01)

L. Spahic, A. Softic, A. Durak-Nalbantic, E. Begic, B. Stanetić, H. Vranic, Integrating Machine Learning in Clinical Decision Support for Heart Failure Diagnosis: Case Study, MEDICON, pp. 696 - 705, Jan, 2024
Gold standard for diagnosing and treating chronic ischaemic coronary artery disease and the associated complications (2024-10)

M. Ostojic, B. Stanetić, Gold standard for diagnosing and treating chronic ischaemic coronary artery disease and the associated complications, Open Heart, Vol. 8, No. 11, Oct, 2024
Left atrial strain analysis in the realm of pediatric cardiology: Advantages and implications. (2024-05)

Z. Begić, M. Djukic, E. Begic, B. Aziri, Z. Mladenović, A. Iglica, N. Sabanovic-Bajramovic, N. Begic, T. Kovačević-Preradović, B. Stanetić, A. Badnjević, Left atrial strain analysis in the realm of pediatric cardiology: Advantages and implications., Technology and Health Care, Vol. 32, No. 3, pp. 1255 - 1272, May, 2024
Coronary Artery Disease And Chronic Obstructive Pulmonary Disease. (2015-05)

Т. Ковачевић-Прерадовић, B. Stanetić, П. Ковачевић, Coronary Artery Disease And Chronic Obstructive Pulmonary Disease., Časopis udruženja pulmologa Republike Srpske, Vol. 5, No. 1-2, pp. 87 - 93, May, 2015
Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption (2015-06)

P. Suwannasom, Y. Onuma, C. Campos, S. Nakatani, Y. Ishibashi, H. Tateishi, M. Grundeken, B. Stanetić, K. Nieman, H. Jonker, H. Garcia-Garcia, P. Serruys, Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 8, No. 8, pp. 1130 - 1132, Jun, 2015
Novel bioresorbable scaffolds technologies: current status and future directions. (2015-08)

B. Stanetić, J. Iqbal, Y. Onuma, P. Serruys, Novel bioresorbable scaffolds technologies: current status and future directions., Minerva Cardioangiologica , Vol. 63, No. 4, pp. 297 - 315, Aug, 2015
Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial. (2015-11)

B. Stanetić, C. Campos, V. Farooq, S. Walsh, Y. Ishibashi, Y. Onuma, H. Garcia-Garcia, J. Escaned, A. Banning, P. Serruys, Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial., CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 15, No. 86, pp. 229 - 238, Nov, 2015
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease. (2016-06)

J. Escaned, A. Banning, V. Farooq, M. Echavarria-Pinto, Y. Onuma, N. Ryan, R. Calvacante, C. Campos, B. Stanetić, Y. Ishibashi, P. Suwannasom, A. Kappetein, D. Taggart, M. Morel, G. van Es, P. Serruys, Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease., EuroIntervention, Vol. 12, No. 2, pp. 224 - 234, Jun, 2016
ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study. (2017-01)

BM. Stanetić, M. Ostojić, C. Campos, J. Marinkovic, V. Farooq, T. Kovačević-Preradović, K. Huber, P. Serruys, ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study., INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol. 227, pp. 478 - 484, Jan, 2017
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies. (2017-02)

C. Collet, T. Asano, Y. Sotomi, R. Calvacante, B. Stanetić, Y. Miyazaki, Y. Zeng, K. Tummala, J. Tijssen, R. De Winter, Y. Onuma, D. Capodanno, P. Serruys, Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies., Minerva Cardioangiologica (Testo stampato), Vol. 65, No. 1, pp. 32 - 51, Feb, 2017

Уноси

Clinical characteristics of patients with COVID-19 (2022-09)

Why patients with COPD visit their doctor so late? (2017-05)

Analysis of stress level and burnout syndrome among physicians of different medical specialties in primary health care. (2019-06)

The Presence of Stress, Burnout Syndrome and the Most Important Causes of Working Stress Among Physicians in Primary Health Care – an Observational Study from Banja Luka, Bosnia and Herzegovina (2019-10)

ApPropRiateness of myOcardial revascUlarization assessed by SYNTAX Scores in patients with type 2 diabetes melliTus: the PROUST study* (2020-06)

Grown-up Congenital Heart Diseases. (2016)

Role of COPD in Decision-Making Process of Myocardial Revascularisation: A Retrospective Analysis from a Single PCI-centre Without On-site Cardiac Surgery. (2015-05)

Chronic Obstructive Lung Disease In Non- Smockers. (2015-05)

High-Sensitive Troponin-T as a Predictive Outcome Factor in COVID-19 Hospitalised Patients: Analysis After One-Year Follow-Up (2021-06)

SYNTAX SCORE II VERSION 2020: EXTERNAL VALIDATION OF PATIENTS TREATED BY CORONARY ARTERY BYPASS GRAFTING IN A SINGLE LARGE VOLUME CARDIO-SURGICAL CENTER (2023-03)

Integrating Machine Learning in Clinical Decision Support for Heart Failure Diagnosis: Case Study (2024-01)

Gold standard for diagnosing and treating chronic ischaemic coronary artery disease and the associated complications (2024-10)

Left atrial strain analysis in the realm of pediatric cardiology: Advantages and implications. (2024-05)

Coronary Artery Disease And Chronic Obstructive Pulmonary Disease. (2015-05)

Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption (2015-06)

Novel bioresorbable scaffolds technologies: current status and future directions. (2015-08)

Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial. (2015-11)

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease. (2016-06)

ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study. (2017-01)

Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies. (2017-02)